Comments

Gilead Sciences

Q: What sector and industry does Gilead Sciences (GILD) operate in?

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GILDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$92.96

1.121.22%

At close: -

$92.96

0.000.00%

After Hours: 6:11 PM EDT

Gilead Sciences (GILD) Forecast

News Earnings Gilead Sciences (GILD) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

Gilead Sciences (NASDAQ:GILD) Stock Quotes, Forecast and News Summary

Gilead Sciences Stock (NASDAQ: GILD) stock price, news, charts, stock research, profile.

Open	$92.06
Close	$92.96
Volume / Avg.	10.55M / 6.79M
Day Range	$92.06 - $93.90
52 Wk Range	62.07 - 98.90
Market Cap	$115.85B
P/E Ratio	1.02K
Dividend Yield	3.35%
Exchange	NASDAQ
RSI	56
Short Interest	2.06%
Days to Cover	3.97

Recent News

This McDonald's Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Avi Kapoor

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Vandana Singh

Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus

Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with €2.45 billion allocated to SpinCo's pipeline.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$92.06
Close	$92.96
Volume / Avg.	10.55M / 6.79M
Day Range	$92.06 - $93.90
52 Wk Range	62.07 - 98.90
Market Cap	$115.85B
P/E Ratio	1.02K
Dividend Yield	3.35%
Exchange	NASDAQ
RSI	56
Short Interest	2.06%
Days to Cover	3.97

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Gilead Sciences (GILD) stock?

You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.

View our list of the best stock brokerages

Who are Gilead Sciences (GILD) competitors?

Other companies in Gilead Sciences’s space includes: BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Gilead Sciences (GILD) stock?

Gilead Sciences has a consensus price target of $97.21.

What is the current price for Gilead Sciences (GILD)?

The stock price for Gilead Sciences (NASDAQ: GILD) is $92.96 last updated January 21, 2025 at 6:11 PM EST.

Does Gilead Sciences (GILD) pay a dividend?

A quarterly cash dividend of 0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on December 30, 2024 to stockholders of record on December 13, 2024.

When is Gilead Sciences (NASDAQ:GILD) reporting earnings?

Gilead Sciences’s Q4 earnings are confirmed for Tuesday, February 11, 2025.

Is Gilead Sciences (GILD) going to split?

There is no upcoming split for Gilead Sciences.

What sector and industry does Gilead Sciences (GILD) operate in?

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.